Recombinant human nerve growth factor (Sichuan ZehaTimes Pharmaceutical)

重组人神经生长因子（四川自豪时代药业）

Report date: 2024/12/18 10:01:28

Base Information

Drug NameRecombinant human nerve growth factor (Sichuan ZehaTimes Pharmaceutical)
Drug Alias Name注射用重组人神经生长因子
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionNeurons stimulantsNerve growth factor receptors agonists
TargetsNerve growth factor receptors
Therapy Area/IndicationsOptic Nerve Injuries
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesSichuan ZehaTimes Pharmaceutical Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesMilitary Medical Institute Academy Of Military Sciences PLA ChinaSichuan ZehaTimes Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsOptic Nerve Injuries
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A